Myocardial reperfusion injury management: erythropoietin compared with postconditioning. [electronic resource]
Producer: 20100217Description: H2035-43 p. digitalISSN:- 1522-1539
- Animals
- Cardiotonic Agents -- therapeutic use
- Coronary Circulation -- drug effects
- Darbepoetin alfa
- Disease Models, Animal
- Erythropoietin -- analogs & derivatives
- Female
- Glycogen Synthase Kinase 3 -- metabolism
- Glycogen Synthase Kinase 3 beta
- Heart Rate -- drug effects
- Mitogen-Activated Protein Kinase 1 -- antagonists & inhibitors
- Mitogen-Activated Protein Kinase 3 -- antagonists & inhibitors
- Myocardial Infarction -- enzymology
- Myocardial Reperfusion Injury -- enzymology
- Myocardium -- enzymology
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- metabolism
- Rats
- Rats, Wistar
- Time Factors
- Ventricular Function, Left -- drug effects
- Ventricular Pressure -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.